Abstract:Hippo pathway is an evolutionarily conservative key pathway that regulates organ size and tissue regeneration by regulating cell proliferation, differentiation and apoptosis. Yes-associated protein 1 (YAP)/ WW domain-containing transcription regulator 1 (TAZ) serves as a pivotal transcription factor within the Hippo signaling pathway, which undergoes negative regulation by the Hippo pathway. The expression of YAP/TAZ affects various biological processes, including differentiation of osteoblasts (OB) and osteoclasts (OC), cartilage homeostasis, skeletal muscle development, regeneration and quality maintenance. At the same time, the dysregulation of the Hippo pathway can concurrently contribute to the development of various musculoskeletal disorders, including bone tumors, osteoporosis (OP), osteoarthritis (OA), intervertebral disc degeneration (IDD), muscular dystrophy, and rhabdomyosarcoma (RMS). Therefore, targeting the Hippo pathway has emerged as a promising therapeutic strategy for the treatment of musculoskeletal disorders. The focus of this review is to elucidate the mechanisms by which the Hippo pathway maintains homeostasis in bone, cartilage, and skeletal muscle, while also providing a comprehensive summary of the pivotal role played by core components of this pathway in musculoskeletal diseases. The efficacy and feasibility of Hippo pathway-related drugs for targeted therapy of musculoskeletal diseases are also discussed in our study. These endeavors offer novel insights into the application of Hippo signaling in musculoskeletal disorders, providing effective therapeutic targets and potential drug candidates for treating such conditions.

Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

Hippo signaling pathway in lung development, regeneration, and diseases.

Molecular mechanisms of the mammalian Hippo signaling pathway.

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

The Emerging Role of Hippo Signaling Pathway in Regulating Osteoclast Formation

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

The Hippo signalling pathway in bone homeostasis: Under the regulation of mechanics and aging

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

Targeting the Hippo Pathway for Anti-cancer Therapies.

The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment

The roles of the Hippo-YAP signalling pathway in Cartilage and Osteoarthritis

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Regulation and Functions of the Hippo Pathway in Stemness and Differentiation.

The Hippo pathway in tissue homeostasis and regeneration

Research progress on Hippo signaling pathway effector molecules in rheumatic immune system diseases

The Multifaceted Roles of Hippo-YAP in Cardiovascular Diseases

An overview of signaling pathways regulating YAP/TAZ activity

WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis